Insights

IRS Notice 2026-16 provides interim guidance on the new 100% depreciation allowance for QPP. Learn the key leasing rules and structuring implications.

Watch our webinar and learn strategic tax planning for 2026: maximize tax credits and incentives, manage SALT risk, and properly utilize NMTC financing.

The finalized Form 6765 instructions mark the IRS's shift to a project-specific disclosure approach. Explore what the new rules mean for R&D tax credits.

Discover how SB 711 reshapes California R&D tax credits for 2026 with ASC adoption, immediate expensing and planning opportunities for businesses.

Uncover the key takeaways from IRS Notice 2026-11, which provides interim guidance on additional first-year deduction depreciation under Section 168(k).

Manufacturers can leverage state tax credits to reduce costs. Learn about key tax subsidies an how they can support business growth.

Discover how Georgia’s tax credit landscape is changing and how to maximize available credits.

Learn how R&D capitalization works, its benefits and about the proposed changes that could affect the existing process under Section 174.

The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.

Starting in the 2025 tax year, the Section 174 repeal lets businesses immediately deduct domestic R&E expenditures. Explore what else is changing.